LANGGARD MORTEN,SIMONSEN KLAUS BAEK,SVENSTRUP NIELS
申请号:
AP2014007820
公开号:
AP2014007820A0
申请日:
2013.01.25
申请国别(地区):
AP
年份:
2014
代理人:
摘要:
The present invention is directed to a compound having the structure (I) for use in a method of treatment which comprises improvement of a condition involving phosphodiesterase type 9 (PDE9) and tautomers and pharmaceutically acceptable acid addition salts thereof, and polymorphic forms thereof.